These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22150947)

  • 1. Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.
    Shields D; Montenegro R; Aclan J
    Neuromodulation; 2007 Oct; 10 Suppl 1():12-7. PubMed ID: 22150947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration.
    Shields DE; Aclan J; Szatkowski A
    Int J Pharm Compd; 2008; 12(6):553-7. PubMed ID: 23969933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration.
    Shields DE; Aclan J; Szatkowski A
    Int J Pharm Compd; 2008; 12(5):463-6. PubMed ID: 23969873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
    Shields D; Montenegro R
    Neuromodulation; 2007 Oct; 10 Suppl 1():6-11. PubMed ID: 22150946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Stability of Admixtures Combining Ziconotide with Morphine or Hydromorphone During Simul ated Intrathecal Administration.
    Shields D; Montenegro R; Ragusa M
    Neuromodulation; 2005 Oct; 8(4):257-63. PubMed ID: 22151554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical stability of an admixture combining ziconotide and bupivacaine during simulated intrathecal administration.
    Shields D; Montenegro R; Aclan J
    Neuromodulation; 2007 Oct; 10 Suppl 1():1-5. PubMed ID: 22150945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.
    Dupoiron D; Richard H; Chabert-Desnot V; Devys C; Leynia P; Boisdron-Celle M
    Neuromodulation; 2014 Jul; 17(5):472-82; discussion 482. PubMed ID: 24512055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.
    Robert J; Sorrieul J; Rossignol E; Beaussart H; Kieffer H; Folliard C; Dupoiron D; Devys C
    Int J Pharm Compd; 2017; 21(4):347-351. PubMed ID: 28719378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pH and temperature on ziconotide stability in intrathecal analgesic admixtures in implantable pumps and syringes.
    Bazin C; Poirier AL; Dupoiron D
    Int J Pharm; 2015 Jun; 487(1-2):285-91. PubMed ID: 25891257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility and Stability of Baclofen 3 mg/mL Intrathecal Formulation and Its Compatibility With Implantable Programmable Intrathecal Infusion Systems.
    Yue B; Brendel R; Lukitsch A; Prentice T; Doty B
    Neuromodulation; 2017 Jun; 20(4):397-404. PubMed ID: 27767242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration.
    Robert J; Sorrieul J; Dupoiron D; Jubier-Hamon S; Bienfait F; Visbecq A; Devys C
    Neuromodulation; 2023 Aug; 26(6):1179-1194. PubMed ID: 35088750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability Study of Admixtures Combining Ziconotide With Morphine or Sufentanil in Polypropylene Syringes.
    Sorrieul J; Robert J; Dupoiron D; Devys C
    Neuromodulation; 2021 Oct; 24(7):1145-1156. PubMed ID: 33095956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports.
    Saulino M; Burton AW; Danyo DA; Frost S; Glanzer J; Solanki DR
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):61-7. PubMed ID: 19156022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskinesia caused by ziconotide-baclofen combination in an adolescent affected by cerebral palsy.
    Pozzi M; Piccinini L; Giordano F; Carnovale C; Perrone V; Pellegrino P; Antoniazzi S; Turconi AC; Radice S; Clementi E
    Reg Anesth Pain Med; 2014; 39(2):172-3. PubMed ID: 24513956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of ranitidine in intravenous admixtures stored frozen, refrigerated, and at room temperature.
    Stewart JT; Warren FW; Johnson SM; Galante LJ
    Am J Hosp Pharm; 1990 Sep; 47(9):2043-6. PubMed ID: 2220860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in the dog.
    Yaksh TL; de Kater A; Dean R; Best BM; Miljanich GP
    Neuromodulation; 2012; 15(6):508-19; discussion 519. PubMed ID: 22748108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilution and compounding of ziconotide for intrathecal administration.
    Buchta T; Fakata K; Stuart W
    Int J Pharm Compd; 2008; 12(3):200-7. PubMed ID: 23969707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of Physicochemical Stability of Ziconotide in Medication Cassette Reservoir.
    Robert J; Sorrieul J; Andrieu A; Mounsef F; Dupoiron D; Devys C
    Neuromodulation; 2020 Oct; 23(7):1034-1041. PubMed ID: 32743885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziconotide combination intrathecal therapy: rationale and evidence.
    Wallace MS; Rauck RL; Deer T
    Clin J Pain; 2010 Sep; 26(7):635-44. PubMed ID: 20639730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.